Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weller

Showing results (691-700 of 831) with videos related to

Pageof 84
Sort By:
JCI Insight|July 12, 2019
Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastomaHans-Georg Wirsching, Huajia Zhang, Frank Szulzewsky, et al.
Journal of Neuro-Oncology|May 6, 2020
Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 studyLinda Dirven, Ralf Luerding, Dagmar Beier, et al.
Acta Neuropathologica|October 25, 2013
Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous systemChristian Koelsche, Felix Sahm, David Capper, et al.
Cell|April 23, 2024
Integrative spatial analysis reveals a multi-layered organization of glioblastomaAlissa C Greenwald, Noam Galili Darnell, Rouven Hoefflin, et al.
The New England Journal of Medicine|November 16, 2017
Lomustine and Bevacizumab in Progressive GlioblastomaWolfgang Wick, Thierry Gorlia, Martin Bendszus, et al.
The Lancet. Oncology|October 30, 2025
Artificial Intelligence for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO), part 1: review of the current state of the artBenjamin H Kann, Arastoo Vossough, Sarah C Brüningk, et al.
Neuro-Oncology Practice|December 14, 2020
Determining medical decision-making capacity in brain tumor patients: why and how?Andrea Pace, Johan A F Koekkoek, Martin J van den Bent, et al.
Neuro-Oncology|May 11, 2026
Discrepancies in Inter-Rater Agreement on Resectability of Recurrent Glioblastoma: Complementary Post-hoc Analysis of the Prospective, Randomized DIRECTOR TrialPhilipp Karschnia, Nico Teske, Emilie Le Rhun, et al.
International Journal of Cancer|June 18, 2026
Clinical Implementation and Oncological Relevance of Molecular Profiling in Brain Metastases Patients-A Multicenter Retrospective Cohort StudyMaria Nikolaeva, Jacopo Bellomo, Meltem Gönel, et al.
Nature Medicine|September 20, 2024
High-throughput identification of repurposable neuroactive drugs with potent anti-glioblastoma activitySohyon Lee, Tobias Weiss, Marcel Bühler, et al.
Pageof 84

Showing results (691-700 of 831) with videos related to

Sort By:
Pageof 84
JCI Insight|July 12, 2019
Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastomaHans-Georg Wirsching, Huajia Zhang, Frank Szulzewsky, et al.
Journal of Neuro-Oncology|May 6, 2020
Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 studyLinda Dirven, Ralf Luerding, Dagmar Beier, et al.
Acta Neuropathologica|October 25, 2013
Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous systemChristian Koelsche, Felix Sahm, David Capper, et al.
Cell|April 23, 2024
Integrative spatial analysis reveals a multi-layered organization of glioblastomaAlissa C Greenwald, Noam Galili Darnell, Rouven Hoefflin, et al.
The New England Journal of Medicine|November 16, 2017
Lomustine and Bevacizumab in Progressive GlioblastomaWolfgang Wick, Thierry Gorlia, Martin Bendszus, et al.
The Lancet. Oncology|October 30, 2025
Artificial Intelligence for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO), part 1: review of the current state of the artBenjamin H Kann, Arastoo Vossough, Sarah C Brüningk, et al.
Neuro-Oncology Practice|December 14, 2020
Determining medical decision-making capacity in brain tumor patients: why and how?Andrea Pace, Johan A F Koekkoek, Martin J van den Bent, et al.
Neuro-Oncology|May 11, 2026
Discrepancies in Inter-Rater Agreement on Resectability of Recurrent Glioblastoma: Complementary Post-hoc Analysis of the Prospective, Randomized DIRECTOR TrialPhilipp Karschnia, Nico Teske, Emilie Le Rhun, et al.
International Journal of Cancer|June 18, 2026
Clinical Implementation and Oncological Relevance of Molecular Profiling in Brain Metastases Patients-A Multicenter Retrospective Cohort StudyMaria Nikolaeva, Jacopo Bellomo, Meltem Gönel, et al.
Nature Medicine|September 20, 2024
High-throughput identification of repurposable neuroactive drugs with potent anti-glioblastoma activitySohyon Lee, Tobias Weiss, Marcel Bühler, et al.
Pageof 84